Korean Circ J.  2019 Aug;49(8):766-768. 10.4070/kcj.2019.0133.

Laboratory Markers Helpful in Diagnosing Kawasaki Disease in Febrile Infant: Role of Age-adjusted Z-values of Blood Cells

• Yoo G

• KMID: 2456872
• DOI: http://doi.org/10.4070/kcj.2019.0133

Abstract

No abstract available.

MeSH Terms

Biomarkers*
Blood Cells*
Humans
Infant*
Mucocutaneous Lymph Node Syndrome*
Biomarkers

Reference

1. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation. 2017; 135:e927–99. PMID: 28356445.

2. Ha KS, Jang G, Lee J, et al. Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr. 2013; 172:343–349. PMID: 23229186.

3. Yamashita M, Ae R, Yashiro M, et al. Difference in risk factors for subtypes of acute cardiac lesions resulting from Kawasaki disease. Pediatr Cardiol. 2017; 38:375–380. PMID: 27878631.

4. Tremoulet AH, Jain S, Chandrasekar D, Sun X, Sato Y, Burns JC. Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J. 2011; 30:1022–1026. PMID: 21817952.

5. Ha KS, Jang GY, Lee J, Lee KC, Son CS. Laboratory markers in incomplete Kawasaki disease according to coronary artery outcome. Korean Circ J. 2018; 48:287–295. PMID: 29625511.

6. Kwak JH, Lee JH, Ha KS. Significance of differential characteristics in infantile Kawasaki disease. Korean Circ J. 2019; 49:755–765. PMID: 31074226.

7. Kang JH, Hong SJ, Seo IA, et al. Early detection of Kawasaki disease in infants. Korean Circ J. 2015; 45:510–515. PMID: 26617654.

8. Chen Y, Hua Y, Zhang C, et al. Neutrophil-to-lymphocyte ratio predicts intravenous immunoglobulin-resistance in infants under 12-months old with Kawasaki disease. Front Pediatr. 2019; 7:81. PMID: 30941338.